(UNVB) Unilever - Ratings and Ratios
Exchange: XETRA • Country: United Kingdom • Currency: EUR • Type: Common Stock • ISIN: GB00B10RZP78
UNVB: Soap, Shampoo, Toothpaste, Mayonnaise, Icecream, Deodorant
Unilever PLC, a stalwart in the fast-moving consumer goods sector, operates across a diverse geographic landscape spanning the Asia Pacific, Africa, the Americas, and Europe. Its strategic segmentation into five distinct categories—Beauty & Wellbeing, Personal Care, Home Care, Nutrition, and Ice Cream—underscores its comprehensive approach to meeting consumer needs. Each segment is tailored to address specific consumer preferences, ensuring a robust market presence.
The Beauty & Wellbeing division is a cornerstone, offering an array of products from hair care essentials like shampoos and conditioners to skin care solutions such as moisturizers. This segment also includes prestige beauty items and health supplements, aligning with the growing consumer interest in wellness. The Personal Care segment, comprising soap, deodorants, and oral care products, highlights Unilevers commitment to daily hygiene and personal grooming.
The Home Care segment addresses fabric care with detergents and conditioners, alongside home hygiene products, reflecting the increasing focus on sustainability and eco-friendly practices. The Nutrition segment is a testament to Unilevers diversification, offering condiments, plant-based meats, and functional nutrition products like Horlicks, which cater to evolving dietary preferences and health-conscious consumers.
With a portfolio of over 400 brands, including Dove, Knorr, and Ben & Jerrys, Unilevers brand equity is a significant asset, providing stability and growth potential. The companys financial metrics, such as a market cap of €136.5 billion and a P/E ratio of 20.97, indicate a strong market position and investor confidence. This, coupled with a forward P/E of 18.25, suggests a positive outlook for future performance.
Headquartered in London since 1860, Unilevers enduring presence is a reflection of its adaptability and commitment to innovation. Its global reach and diversified product lines make it a compelling investment opportunity, particularly for those seeking stability in the consumer goods sector.
Additional Sources for UNVB Stock
UNVB Stock Overview
Market Cap in USD | 150,896m |
Sector | Consumer Defensive |
Industry | Household & Personal Products |
GiC Sub-Industry | Personal Care Products |
IPO / Inception |
UNVB Stock Ratings
Growth Rating | 42.4 |
Fundamental | 73.0 |
Dividend Rating | 48.0 |
Rel. Strength | 14.9 |
Analysts | - |
Fair Price Momentum | 48.78 EUR |
Fair Price DCF | 105.20 EUR |
UNVB Dividends
Dividend Yield 12m | 3.74% |
Yield on Cost 5y | 4.97% |
Annual Growth 5y | 0.21% |
Payout Consistency | 97.7% |
UNVB Growth Ratios
Growth Correlation 3m | -0.5% |
Growth Correlation 12m | 39.4% |
Growth Correlation 5y | 66.6% |
CAGR 5y | 6.05% |
CAGR/Max DD 5y | 0.27 |
Sharpe Ratio 12m | 2.12 |
Alpha | 24.45 |
Beta | -0.053 |
Volatility | 27.66% |
Current Volume | 15.6k |
Average Volume 20d | 23.7k |
As of April 19, 2025, the stock is trading at EUR 56.00 with a total of 15,590 shares traded.
Over the past week, the price has changed by +3.59%, over one month by +3.90%, over three months by +3.02% and over the past year by +30.87%.
Yes, based on ValueRay Fundamental Analyses, Unilever (XETRA:UNVB) is currently (April 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 72.95 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of UNVB as of April 2025 is 48.78. This means that UNVB is currently overvalued and has a potential downside of -12.89%.
Unilever has no consensus analysts rating.
According to ValueRays Forecast Model, UNVB Unilever will be worth about 52.7 in April 2026. The stock is currently trading at 56.00. This means that the stock has a potential downside of -5.93%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 52.7 | -5.9% |